ABT Abbott Laboratories

Price (delayed)

$134.28

Market cap

$233.71B

P/E Ratio

16.79

Dividend/share

$2.32

EPS

$8

Enterprise value

$240.19B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
The EPS has soared by 152% YoY and by 3.6% from the previous quarter
Abbott Laboratories's net income has surged by 152% YoY and by 3.5% QoQ

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.74B
Market cap
$233.71B
Enterprise value
$240.19B
Valuations
Price to earnings (P/E)
16.79
Price to book (P/B)
4.6
Price to sales (P/S)
5.43
EV/EBIT
28.5
EV/EBITDA
20.76
EV/Sales
5.57
Earnings
Revenue
$43.11B
Gross profit
$24.15B
Operating income
$7.52B
Net income
$13.98B
EBIT
$8.43B
EBITDA
$11.57B
Free cash flow
$6.78B
Per share
EPS
$8
EPS diluted
$7.97
Free cash flow per share
$3.89
Book value per share
$29.21
Revenue per share
$24.73
TBVPS
$31.05
Balance sheet
Total assets
$84B
Total liabilities
$33.17B
Debt
$13.44B
Equity
$50.83B
Working capital
$11.03B
Liquidity
Debt to equity
0.26
Current ratio
1.82
Quick ratio
1.14
Net debt/EBITDA
0.56
Margins
EBITDA margin
26.8%
Gross margin
56%
Net margin
32.4%
Operating margin
17.4%
Efficiency
Return on assets
17.4%
Return on equity
29.8%
Return on invested capital
19.5%
Return on capital employed
11.9%
Return on sales
19.6%
Dividend
Dividend yield
1.73%
DPS
$2.32
Payout ratio
29%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
1.68%
1 week
5.49%
1 month
0.69%
1 year
22.34%
YTD
18.72%
QTD
-1.27%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$43.11B
Gross profit
$24.15B
Operating income
$7.52B
Net income
$13.98B
Gross margin
56%
Net margin
32.4%
Abbott Laboratories's net income has surged by 152% YoY and by 3.5% QoQ
Abbott Laboratories's net margin has surged by 138% YoY
The operating income has grown by 16% YoY and by 5% from the previous quarter
Abbott Laboratories's operating margin has increased by 9% YoY and by 3.6% from the previous quarter

Price vs fundamentals

How does ABT's price correlate with its fundamentals

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
16.79
P/B
4.6
P/S
5.43
EV/EBIT
28.5
EV/EBITDA
20.76
EV/Sales
5.57
The EPS has soared by 152% YoY and by 3.6% from the previous quarter
ABT's P/E is 47% below its 5-year quarterly average of 31.0 and 21% below its last 4 quarters average of 20.9
ABT's equity is up by 28% year-on-year and by 3.6% since the previous quarter
ABT's price to book (P/B) is 15% lower than its 5-year quarterly average of 5.3
ABT's P/S is 9% above its 5-year quarterly average of 4.9 and 4.7% above its last 4 quarters average of 5.1
The revenue has grown by 6% YoY

Efficiency

How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has surged by 129% YoY
ABT's ROE has soared by 108% YoY but it is down by 2.6% from the previous quarter
The ROS has grown by 12% YoY and by 4.8% from the previous quarter
The ROIC has contracted by 3.5% YoY

Dividends

What is ABT's dividend history
DPS
$2.32
Dividend yield
1.73%
Payout ratio
29%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 153% more than the total liabilities
The total assets has grown by 15% YoY and by 3.1% from the previous quarter
ABT's quick ratio is up by 12% year-on-year and by 4.6% since the previous quarter
Abbott Laboratories's debt is 74% lower than its equity
Abbott Laboratories's debt to equity has decreased by 30% YoY and by 3.7% from the previous quarter
ABT's equity is up by 28% year-on-year and by 3.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.